Back
ARK Innovation ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
81
ARKK
ARK Innovation ETF
Last Price:
$76.78
Seasonality Move:
-5.18%
Sell
31
APLS
Apellis Pharmaceuticals
Last Price:
$19.59
Seasonality Move:
-8.3%
Buy
81
ARK Innovation ETF (ARKK)
is a Buy
Is ARK Innovation ETF a Buy, Sell or Hold?
-
The current ARK Innovation ETF [ARKK] share price is $76.79. The Score for ARKK is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
-
ARKK is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
31
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $19.59. The Score for APLS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARKK Stock Price Chart
What is ARK Innovation ETF's stock price today?
-
The ARK Innovation ETF share price today is $76.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARKK is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $19.59The current trend is moderately bullish and APLS is experiencing slight selling pressure.
ARKK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.21 | Buy |
Relative Strength Index (14 RSI): | 66.54 | Buy |
Chaikin Money Flow: | 5780084 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (69.65 - 75.65) | Buy |
Bollinger Bands (100): | (47.49 - 67.77) | Buy |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.41 | Buy |
Relative Strength Index (14 RSI): | 54.73 | Buy |
Chaikin Money Flow: | -1363320 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.86 - 19.76) | Buy |
Bollinger Bands (100): | (17.19 - 22.45) | Sell |
ARKK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 76.53 | Buy |
20-day SMA: | 73.44 | Buy |
50-day SMA: | 65.98 | Buy |
200-day SMA: | 57 | Buy |
8-day EMA: | 75.99 | Buy |
20-day EMA: | 73.38 | Buy |
50-day EMA: | 67.31 | Buy |
200-day EMA: | 57.67 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.75 | Sell |
20-day SMA: | 18.97 | Buy |
50-day SMA: | 18.45 | Buy |
200-day SMA: | 24.83 | Sell |
8-day EMA: | 19.67 | Sell |
20-day EMA: | 19.24 | Buy |
50-day EMA: | 19.13 | Buy |
200-day EMA: | 25.25 | Sell |
ARK Innovation ETF Earnings Growth & ARKK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.39 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
ARK Innovation ETF Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |